Italia markets closed

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
3,5200+0,0500 (+1,44%)
Alla chiusura: 04:00PM EDT
3,6700 +0,15 (+4,26%)
Dopo ore: 05:48PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente3,4700
Aperto3,5000
Denaro3,4600 x 1400
Lettera3,6900 x 900
Min-Max giorno3,5000 - 3,6900
Intervallo di 52 settimane3,3000 - 48,6000
Volume89.480
Media Volume88.019
Capitalizzazione23,317M
Beta (5 anni mensile)2,23
Rapporto PE (ttm)N/D
EPS (ttm)-14,8540
Prossima data utili04 ago 2022 - 08 ago 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A40,00
  • GlobeNewswire

    Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    DEERFIELD, Ill., June 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restricted stock unit awards to five (5) employees, none of whom was an executive officer, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 27,877 shares of Surgalign common

  • GlobeNewswire

    Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split

    DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that at its Annual Meeting of Stockholders (“Annual Meeting”) on May 10, 2022, the Board and stockholders of the Company approved a reverse stock split of the Company’s issued and outstanding shares of its common stock and authorized the Board to select the ratio of the

  • GlobeNewswire

    Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range

    DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 first quarter ended March 31, 2022. Financial Highlights and Key Events: Received FDA 510(k) clearance for HOLO Portal™ System, the world's first AI-driven AR guidance system for spine surgery;1st Holo Portal™ site up and running;1st succe